<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=601572900419438&amp;ev=PageView&amp;noscript=1">


About Northway Biotech US

Northway Biotech is a flexible biologics CDMO with a facility in a Greater Boston area, a world-leading hub in the field of life sciences research and drug development.

Our global teams based in the US and Europe are exceptionally well-versed in all aspects of the biopharmaceutical value chain, from cell line development to commercial production and aseptic fill-finish.

Our brand new, state-of-the-art facilities include R&D labs for cell line development, USP and DSP processes establishment and analytical support. cGMP manufacturing suite with both single-use and stainless steel systems for upstream and downstream process development, formulation and fill-finish of microbial and mammalian cell culture-based products will be fully functional in 2021.

We are deeply invested in providing high quality, world-class CDMO services and long-term partnerships based on our blend of experience and openly collaborative project teams.


Management US

Vladas Bumelis}

Vladas Algirdas Bumelis Ph.D.

Executive Chairman of BoD & Advisory Board

Dr. Vladas Bumelis is the Founder of Northway Biotech and Chairman of the company’s Board of Directors and Advisory Board.
He has extensive experience in the pharmaceutical and biotech industries, having previously served as General Manager of Sicor Biotech UAB (now Teva Pharmaceutical Industries Ltd.), Chairman of the Board for the biotech companies Biofa and Biotechna, and Chairman of the Board and General Manager of the Institute of Applied Enzymology in Lithuania.
In 2004, Dr. V.Bumelis received the Science Award of Lithuania in recognition of his achievements in the development and production of recombinant proteins. He has a Ph.D. and MSc in chemistry, as well as a Ph.D. in biotechnology from Vilnius University.

Tomas }

Tomas Bubinas

Chief Financial Officer

Tomas has more than 20 years of pharmaceutical and biotechnology industry experience. Prior to joining Northway Biotechpharma, he served as Senior Director, Operations, for Teva Biopharmaceuticals USA, previously serving as CFO of Teva Baltics and Finance Director at Sicor Inc. Tomas has both BSc and MSc in economics and an Executive MBA.

Francis B. Maddalo}

Francis B. Maddalo

Site Head / Director of US Operations

Francis B. Maddalo holds MSc in Physiology/Virology and BSc in Biology.
Francis B. Maddalo is a highly experienced manager with over 25 years of experience in different areas of manufacturing of biologics, drugs, and medical devices. His areas of expertise include process optimization, product development as well as CMC regulatory, and others.


Dominic Chow, Ph.D.

Sr. Director, Process Development

Dr. Dominic Chow has an MSc and a Ph.D., both in Chemical Engineering from Northwestern University and he did his post-doc in Biomedical Engineering at Duke University.
Dominic has been working in the biotechnology and biopharmaceutical industry for more than 15 years. He specializes in process development and characterization, technology transfer, scale-up, and manufacturing support for biologics (monoclonal antibodies, enzymes, and recombinant proteins) and novel therapeutics (antibody-drug conjugates and mRNAs). He previously worked for Lonza Biologics, Bristol-Myers Squibb, ImmunoGen, and Moderna.

Nick M}

Nick Maragos

Vice President, Business Development, East Coast

Nick Maragos holds a BSc in Biology from The University of Akron. He has over 25 years of Sales and Marketing experience coming from medical device and biotechnology companies. Nick most recently worked for Celonic and Rentschler Biopharma where he was responsible for Business Development both in Europe and the USA.


Rose Rhomberg

Director, Business Development, West Coast

Rose Rhomberg has more than 20 years of sales experience in highly technical fields including electro-optics, acoustics, and biologics. Her contract development and manufacturing experience is in mammalian cell culture. Rose understands the voice of the customer and is focused on building relationships with companies that will benefit from Northway Biotech’s services.
Rose graduated with an economics degree from Claremont Mckenna College in Claremont, California and then from the MBA-executive track program at the Eberly College of Business, Indiana University of Pennsylvania as a Delta Epsilon Iota member.